These data, combined with the neuroinflammatory marker profile, suggest that neither AAC2 nor AAC2–INS nanofibers promote amyloidogenic and proinflammatory genes in AD pathogenesis beyond those seen in untreated APP/PS1 mice. Here, APP is linked to Alzheimer disease.